Structural differences of orthologous genes: Insights from human–primate comparisons  by Lee, Tuan Meng & Lipovich, Leonard
Genomics 92 (2008) 134–143
Contents lists available at ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r.com/ locate /ygenoStructural differences of orthologous genes: Insights from human–primate comparisons
Tuan Meng Lee a,b,c, Leonard Lipovich a,b,*
a School of Computer Engineering, Nanyang Technological University, Singapore
b Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore
c Alexandra Hospital, National Healthcare Group, Singapore* Corresponding author. Present address: Center
Genetics, Wayne State University, Detroit, MI 48201-192
E-mail address: llipovich@med.wayne.edu (L. Lipovi
0888-7543/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.ygeno.2008.05.006a b s t r a c ta r t i c l e i n f oArticle history: The genomic basis of phen
Received 26 September 2007
Accepted 2 May 2008
Available online 7 July 2008
Keywords:
Comparative genomics
Intergenic splicing
Bioinformatics
Primates
Gene structure
cDNAotypic distinctions between humans and nonhuman primates remains insufﬁ-
ciently explained. We hypothesized that interspecies structural differences of orthologous genes can cause
such distinctions and searched protein-coding genes conserved between humans and nonhuman primates
for species-speciﬁc initial and terminal exons. We inferred gene structure differences from genomic locations
where portions of primate transcripts aligned with the human genome outside of any human exons. Of
22,466 high-conﬁdence FANTOM3 human transcriptional units, 7424 (33k) had nonhuman primate full-
length cDNA support. One hundred eighty-three of the loci contained 68,424 bp of sequence exonic in
nonhuman primates but not humans. Fifty-four of 183 included species-speciﬁc portions of protein-coding
regions. Six genes had evidence of intergenic splicing in a nonhuman primate but not in human. It is
imperative that primate transcriptome projects be accelerated on par with genome projects to understand
better interspecies gene structure distinctions.
© 2008 Elsevier Inc. All rights reserved.The human interest in improving our health is intimately linked to
the argument that certain organismal characteristics, including those
relevant to disease, are uniquely human. That argument is bolstered
by the numerous differences in pathology, anatomy, and behavior
between humans and nonhuman primates. We are more susceptible
than the great apes to speciﬁc diseases: AIDS, myocardial infarction,
and hepatitis B/C complications [1]. Chimpanzee–human sequence
identity surpasses 98k in alignable genomic regions [2]. Humans and
chimpanzees are profoundly phenotypically different in many addi-
tional ways, but speciﬁc genetic features responsible for most of the
differences are unelucidated.
Several approaches have been historically employed to explain
interspecies phenotypic differences [1]. One has centered on com-
parative genomics of conserved regions. The mouse, a key model
organism, is believed to have shared a common ancestor with humans
75–80 million years ago [3]. Due to neutral divergence and selective
pressures, genomic differences have arisen since the primate–rodent
divergence. For instance, low-copy repeats and segmental duplications
have undergone lineage-speciﬁc accretion during primate evolution
[4]. Accordingly, human–mouse comparisons can miss functional
regions arising uniquely along the primate lineage [3].
While the evolutionary distance to mouse introduces limitations,
comparisons of the human genome to closely related species can yieldfor Molecular Medicine and
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l rights reserved.false positive results: nonfunctional regions appear conserved, as
there is not enough time for mutation to occur. Phylogenetic shado-
wing can address this problem. Regions consistently conserved among
multiple species are identiﬁed by this method and have a higher
probability of being functional (see Fig. 1, [5]).
In-depth analysis of chromosomal changes, indels, repeats, dupli-
cations, and gene conversions has been used to study interspecies
distinctions in genomic alignments. These distinctions at multiple loci
contribute to differences between humans and nonhumanprimates by
affecting genes and regulatory regions directly [2,6–8].
Gene duplication, either segmental or retrotransposition-media-
ted, can create new genes with new biological functions. Duplicated
genes can become nonfunctional (pseudogenes), neofunctional (ac-
quire a new function), or subfunctional (adopt a portion of the previous
function) [9]. Up to 30k of human segmental duplications have taken
place since the human–chimpanzee common ancestor split [10]. There
are 200–300 species-speciﬁc retroposed gene copies in humans and
chimpanzees [2]. Both duplication types may be neofunctional in a
species-speciﬁc manner.
Interspersed repetitive elements, especially the primate-speciﬁc
Alu subclass of SINEs, have contributed profoundly to primate evo-
lution. Alu insertions have affected the open reading frames of
protein-coding genes [11], served as markers distinguishing primate
species [12], and may even have facilitated the evolution of large
brains in humans by inactivating the gene for a cell-surface glyco-
protein that interacts with etiologic agents of bacterial meningitis [13].
Another existing perspective on phenotypic uniqueness entails
searches for gene signatures of human-speciﬁc rapid evolution. High
Fig. 1. Distribution of the number of nonhuman primate xenoMrnas per human TU.
(A) TUs with six or fewer supporting xenoMrnas. (B) TUs with seven or more supporting
xenoMrnas.
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property of genes undergoing accelerated evolution and positive
selection [14]. An additional perspective focuses on non-protein-
coding sequence changes. In a key early study, King and Wilson
revealed that human and chimpanzee protein-coding sequences are
highly similar. They proposed that conserved genes may be regulated
differently between the two species, inﬂuencing phenotypic differ-
ences [15]. More recently, Glazko et al. found that 80k of proteins are
different between the human and the chimpanzee, although the
speciﬁc differences may be too minor to explain phenotypic distinc-
tions. The phenotypic differences may be controlled by a few
regulatory or major-effect genes [16].
Recent cDNA cloning projects and genome-tiling array experiments
reveal that half or more of the transcriptome does not encode proteins
[17,18] and suggest that noncoding RNAs (ncRNAs), including ones not
conserved between species, merit consideration as contributors to
species distinctions. Previously described ncRNAs (such as tRNAs,
rRNAs, spliceosomal RNAs, catalytic RNAs, and small RNAs) play
essential roles, suggesting that other ncRNAs can also be functional.
From 512 FANTOM2 mouse ncRNA sequences conserved in human, 8
functional ncRNAswere identiﬁed [19]. However, most ncRNAs are not
conserved, which does not imply lack of function [20], becausemetrics
other than exon conservationmaybemore appropriate gauges of these
RNAsT functionality [21]. Medically important human ncRNAs include
DLEU2, 7H4, and BIC, implicated in lymphocytic leukemia, postnatal
development, and Hodgkin lymphoma, respectively [3].
NcRNAs exert regulatory effects by hybridizing tomRNAmolecules,
as trans- and cis-antisense transcripts (in prokaryotes and eukaryotes)
and as microRNAs in eukaryotes, which favor 3Vuntranslated regions
(3VUTRs). Therefore, a better understanding of gene structure differ-
ences, including at UTRs, may help understand species-speciﬁc gene
expression regulation by ncRNAs.Interspecies comparisons of gene expression levels represent
another approach used to link genomic and phenotypic distinctions,
as it is difﬁcult to predict changes in gene expression purely by com-
paring genomic sequences [22]. Microarrays based on human se-
quences may not always detect expression changes or alternative
splicing in nonhuman primates, due to human–primate divergence at
probe-homologous regions [23]. Moreover, expression differences can
be due to neutral evolution [24]. Finally, many functional products are
not proteins, but result from their enzymatic activity (e.g., lipids,
glycans, and bioactive small molecules). Thus, gene expression studies
should be complemented by other approaches, including lipomics and
glycomics [1].
Entirely primate-speciﬁc genes, while rare, constitute yet another
potential explanation for human–primate phenotypic differences. De
novo birth of brain-expressed genes has taken place in the hominid
lineage by complex mutational, antisense, and retropositional mecha-
nisms [25], and primate-speciﬁc repetitive sequences have contrib-
uted to exons of new genes with brain expression [26], leading to
conclusions that gene genesis has played a role in the accretion of
primate evolutionary novelties [27].
Several assumptions have historically dominated genetics [28].
These include the one gene–one protein rule, the Central Dogma, and
the deterministic perspective on gene expression. Venter et al. rein-
troduced the term btranscriptional unit (TU),Q originally used in the
1970s to describe ribosomal-RNA operons, to refer to gene models,
including those distinct from known genes, supported by multiple
levels of evidence, including cDNAs and ESTs [29,30]. We deﬁne a TU
as a collection of all known transcripts sharing any exonic sequences
on the same strand in the same locus [31].
We have coupled a published human TU catalog to a novel frame-
work for enumerating human–primate distinctions. The limitations of
existing perspectives on interspecies differences inspired us to
examine a class of genomic distinctions that has rarely, and usually
in single-gene case studies, been investigated to date: orthologous
gene structure differences evident from aligning human and nonhu-
man primate cDNAs to human genomic regions. This approach en-
abled us to utilize all publicly available primate transcriptome
sequences, including those from species lacking sequenced genomes.
Gene structure differences thereby revealed can be phenotypically
relevant because they indicate unique protein-coding DNA sequence
(CDS) and UTR subsequences of orthologous human and primate
genes. The unique subsequences may result in species-speciﬁc protein
portions and species-speciﬁc regulation by mRNA-binding ncRNAs
and/or RNA-binding proteins, respectively.
The goal of the present study was to search for initial-exon and
terminal-exon gene structure differences at orthologous loci between
humans and nonhuman primates, using transcript-to-genome align-
ments. Attaining this goal, we compiled a quantitative catalog of or-
thologous gene structure differences that involve initial or terminal
exons or exon fragments unique to nonhuman primates.
Results
Only a subset of human TUs is supported by nonhuman primate cDNAs
The initial high-conﬁdence FANTOM3 [33] TU dataset comprised
22,466 TUs, approximately 59k of the 38,037 total FANTOM3 TUs that
had been successfully mapped to the HG18 human genome assembly.
The remaining 41k were not considered because they were not
supported by human cDNAs or multiple human ESTs. We matched the
19,699 nonhuman primate GenBank cDNAs (Supplementary File
bdistinct nonhuman primate cDNAs.xlsQ) mappable to the HG18
assembly with speciﬁc human TUs mappable to that assembly,
capturing the species origin of each nonhuman primate cDNA in the
process. The genomic coordinate ranges of 6893 nonhuman primate
cDNAs, when mapped to the human genome, did not overlap any
Table 1A
Categorization of unique structures found at terminal exons of nonhuman primates
based on individual nonhuman primate transcripts
UTR and CDS content of
primate-speciﬁc exons
absent in human
Number of distinct
nonhuman primate
cDNAs
5′UTR only 99
CDS only 10
3′UTR only 51
5′UTR and CDS 41
CDS and 3′UTR 10
5′UTR, CDS, and 3′UTR 9
Total 220
55 super-high-conﬁdence TUs
5′UTR only 31
CDS only 0
3′UTR only 13
5′UTR and CDS 5
CDS and 3′UTR 0
5′UTR, CDS, and 3′UTR 6
Total 55
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artifacts or genes absent from the humanTU dataset were not pursued
further. Of the initial dataset, 7424 (33k) TUs were supported by
12,806 nonredundant nonhuman primate cDNA accessions (Fig. 1;
Supplementary File bhigh conﬁdence TUs w/ supporting xenomrna if
any.xlsQ). The results indicate that themajority of humanTUs currently
lack nonhumanprimate cDNA support and highlight a need for deeper
sequencing of primate transcriptomes. Such sequencing would enable
more thorough human–primate ortholog gene comparisons that
exploit actual exon–intron structures of expressed genes, not just
genomic sequence alignments.
Nonhuman primate cDNAs reveal candidate terminal-exon differences at
orthologous loci
For 2488 nonhuman primate cDNAs (listed in Supplementary File
bdistinct nonhuman primate cDNAs.xlsQ as [largetstart,largetend]),
both the start and the end of each cDNA were N1kb distant from the
start and end of any human TU reference transcript. These primate
cDNAs might reﬂect mapping artifacts, correspond to genes not sup-
ported by high-conﬁdence human TUs, and/or have abnormally long
human genomic spans because of cDNA library chimerism, and hence
they were not analyzed further.
A set of 5371 (listed in Supplementary File bdistinct nonhuman
primate cDNAs.xlsQ as [smalltstart,smalltend]) nonhuman primate
cDNAs had both start and end aligning within 1 kb of the start and
end, respectively, of a high-conﬁdence human TU. These primate
cDNAs most likely reﬂected expression from primate orthologs of the
human TUs. But since they lacked evidence of major structural differ-
ences in the 5′- and 3′-end positions between primates and humans,
they were also not considered further.
Elimination of the 2488 primate cDNAs with large differences at
both ends relative to human genes and the 5371 primate cDNAs that
recapitulate human gene structures without terminal differences
resulted in 5250 prospective cases of orthologous-loci terminal-exon
differences. Of the 5250 cases, 4811 involved a primate cDNA with
b1kb difference in mapping to the human genome at one end relative
to the orthologous human cDNA and a difference of between 1 and 100
kb at the other end. We did not analyze those cases, even though they
might represent a pool of bona ﬁde interspecies differences useful in
future studies; we anticipated that differences of greater than 100 kb
presented greater potential for conﬁrmation as readily evident, and
major, orthologous-gene structure distinctions. Therefore, we manu-
ally annotated only the cases (Supplementary File blist of 439 ortho-
logous pairs.xlsQ) in which one end of a nonhuman primate cDNA,
mapped to the human genome, was b1kb away from the end of the
orthologous human gene, while the other end of that nonhuman
primate cDNA was N100kb away from the other end of that human
gene.
Of the 439 cases, 208 were eliminated: 171 lacked terminal-exon
interspecies differences upon manual inspection in the UCSC Genome
Browser [33] or belonged to knownTCR andMHC lociwhose repetitive
nature made interpretation difﬁcult, and 37 had ambiguous multiple
genomic mappings. A further 2 duplicate records and 9 instances of
putative intergenic splicing, to be discussed further, were also
separated (Supplementary File blist_of_439_orthologous_pairs.xlsQ).
Hence, we extracted 220 individual nonhuman primate cDNAs, which
corresponded to 183 unique human genes (Supplementary File blist of
distinct human accession nos that feature structural differences at
terminal ends.xlsQ) for subsequent analysis.
Sequences transcribed uniquely in nonhuman primates contribute to
protein-coding and untranslated regions of conserved genes
To weigh the relative contributions of species-speciﬁc exons of
orthologous genes to protein sequence, vs via UTRs, we quantitatedtwo metrics: number of nonhuman primate cDNAs that had species-
speciﬁc UTR and/or CDS and amounts (bp) of CDS and UTR sequence
contained in those primate-speciﬁc terminal exons thatwere exclusive
to nonhuman primate cDNAs (Tables 1A, B).
We ﬁrst considered 220 nonhuman primate cDNAs corresponding
to all 183 genes with evidence of species-speciﬁc terminal exons
(Supplementary File bcategorisation of unique terminal exons.xlsQ).
One hundred ﬁfty of the 220 nonhuman primate cDNAs had species-
speciﬁc regions that contained only UTR sequence. The remaining 70
contained at least some protein-coding sequence. Therefore, most
frequently, exonic sequence unique to a nonhuman primate cDNAwas
conﬁned to a UTR (Table 1A). In order of decreasing total affected
sequence length, 5′UTR bases were most frequently affected by cDNA-
supported terminal-exon differences between humans and non-
human primates. They were followed by 3′UTRs and then by CDS
(Table 1B).
A subset of species-speciﬁc terminal exons in primates is completely
devoid of human cDNA and human EST support
The 183 human genes with species-speciﬁc terminal exons in or-
thologous primate cDNAs had primate-speciﬁc terminal exons absent
from themajority of, but not necessarily all, orthologous human cDNAs
and ESTs. Therefore, some of those primate terminal exons provided
conﬁrmation that speciﬁcminor-frequency human alternative splicing
events affecting terminal exons occurred at orthologous primate
genes, but did not provide evidence for primate-speciﬁc exons com-
pletely unused in humans. To distinguish between those two possibi-
lities,wedeﬁned a subset of human/primate terminal-exondifferences
completely unsupported by human cDNA/EST data.
Fifty-ﬁve human genes (Supplementary File bcategorisation of 55
superhigh conﬁdence TUs.xlsQ) had nonhuman primate orthologous
cDNAs with terminal-exonic sequences completely devoid of human
cDNA and EST support. We refer to these 55 genes as the bsuper-high-
conﬁdenceQ subset of the 183. Because of the much greater depth of
human vs nonhuman transcriptome coverage in public cDNA/EST
databases, it is unlikely that the terminal exons observed in nonhuman
species for those 55 genes are used in any orthologous human
transcripts.
The relative proportions of species-speciﬁc sequences correspond-
ing to translated and untranslated regions, as observed in all 183 genes,
were recapitulated in these 55 genes. Speciﬁcally, the 5′UTR category
still ranked ﬁrst and the CDS category still ranked last; the number of
Table 2
Classiﬁcation of human genes that have terminal-exon structure differences
demonstrable by nonhuman-primate cDNA comparisons, using a variety of tools,
shows that protein-related activities are consistently overrepresented based on a cutoff,
adjusted P value b0.015
Tool Process Adjusted P
David (http://david.abcc.ncifcrf.gov/
summary.jsp)
Protein binding 5.6×10−6
FuncAssociate (beta version)
(http://llama.med.harvard.edu/cgi/
func/funcassociate)
Negative regulation of protein
metabolic process
b0.001
Protein depolymerization b0.001
Genecodis (http://genecodis.dacya.
ucm.es/)
Protein binding 1.28×10−2
Panther (http://www.pantherdb.org)
Reference list: human AB1700 genes Protein phosphorylation 4.69×10−3
G-protein modulator 1.04×10−3
Select regulatory molecule 4.77×10−3
Membrane trafﬁc protein 1.48×10−2
Select calcium-binding protein 1.25×10−2
Reference list: NCBI H. sapiens genes Protein phosphorylation 9.10×10−3
G-protein modulator 3.64×10−3
Select regulatory molecule 1.31×10−2
Accessed on August 23, 2007. bUnclassiﬁedQ functions are omitted.
Table 1B
Number of base pairs of unique primate-speciﬁc exonic sequences
5′UTR CDS 3′UTR Total No. of bp
TUs 28,586 14,152 25,686 68,424
55 super-high-conﬁdence TUs 7,264 3,307 5,358 15,929
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roughly half the number of base pairs of species-speciﬁc 5′UTRs
(Table 1B). However, there was a reduction in the absolute number
of nonhuman primate cDNAs whose species-speciﬁc terminal exons
affected the CDS (Table 1A). Therefore, UTRs detected byour analysis as
unique to nonhuman primate cDNAs may be more likely to be
completely devoid of human cDNA and EST support, while CDS regions
detected by our assessment are more likely to be present in minor-
frequency splice variants of the corresponding human orthologs.
Nearly half (26) of the nonhuman primate genes whose unique
species-speciﬁc exons lacked any human cDNA or EST support are
involved directly in biological or evolutionary aspects of primate
uniqueness (deﬁned to include cancer, brain function, neurodegen-
erative disease, immunity, glycoproteins, reproduction, rapid evolu-
tion, and positive selection) (Supplementary File bgene names of 55
superhigh conﬁdence TUs.xlsQ). Speciﬁc genes included two relevant
to HIV and SIV infection (APOBEC-binding HNRPAB and NFAT5), a
brain size gene mutated in neurodegenerative disorders and known to
be affected by segmental duplications and structural polymorphism
(myomegalin), and multiple glycoprotein biosynthesis enzymes,
important because cell-surface glycoprotein differences are promi-
nent in primates [34]. Thirteen of the 55 genes, including 2 expressed
in brain, were involved directly in cancer pathways, suggesting that
primate-speciﬁc gene structure differences at cancer loci, in addition
to coding-sequence differences between orthologous human and
chimpanzee cancer genes [35], may be relevant to the differential
incidence of cancers between primate species.
Speciﬁc protein functions are putatively enriched in human genes with
terminal-exon differences relative to primates
To test for enrichment or depletion of speciﬁc biological functions
within a subset of genes, gene ontology classiﬁcations can be retrieved
for all genes in the set, and the frequencies of encountering each
classiﬁcation can be compared with those in the entire human gene
catalog. We hypothesized that genes encoding speciﬁc biological
functions potentially relevant to human–primate phenotypic distinc-
tions may be enriched among our 183 genes with human–primate
terminal-exon differences and/or in our super-high-conﬁdence subset
of 55 of those genes. To test this hypothesis, we subjected both gene
sets to enrichment and depletion analysis using two robust con-
trolled-vocabulary ontology systems, PantherDB and GO, with multi-
ple-testing correction. Three independent tools were used for GO
enrichment analysis [36–39].
Speciﬁc processes involving protein interactions, including protein
depolymerization, posttranslational modiﬁcations, cytoskeletal func-
tions, and calcium binding, were enriched in the 183-gene set and
consistently detected by all four tools at Pb0.015 (Table 2). This
contrasts with historical expectations of primate-speciﬁc functions
limited to neuronal activities, synaptogenesis, reproduction, and
immunity. Speciﬁc protein-interaction-related processes might be
relevant to phenotypic differences between humans and primates
because of their link to HIV infection: interactions of host and HIV
proteins inﬂuence the dimerization of the transcriptase (p51/p66),
while cell-fusion processes are important for viral spread and there-
fore are potential targets in drug design [40]. We speculate that the
distinctions between the human immune response to HIV and thechimpanzee immune response to SIV might be encoded by structure
differences at orthologous genes in the functional categories detected
as enriched in our unique-terminal-exon orthologous-pair dataset.
Overrepresentation of PantherDB categories describing neuronal
and synaptic functions was observed in our starting datasets (the
22,466 high-conﬁdence human TUs and the 7424 human TUs
supported by nonhuman primate cDNAs). This was likely due to a
bias in favor of genes with these functions in human TU and primate
cDNA datasets, as brain and neuronal transcriptome libraries might be
sequenced more deeply or more frequently than other cDNA libraries.
Novel intergenic splicing events unique to primates are suggested by
nonhuman primate cDNA alignments to the human genome
We detected six cases of intergenic splicing supported by nonhu-
man primate cDNA data (Fig. 2A). Intergenic splicing refers to the
joining of exons from genomically adjacent but biologically separate
genes within a single mRNA and is rarely observed inmammals [41]. A
representative instance of intergenic splicing unique to the nonhuman
primate cDNA set is illustrated in Fig. 2B. All cases except one
(CYP2C19–CYP2C9 [42]) involve genes not previously known to be
intergenically spliced. Because intergenic splicing as deﬁned here is
internal rather than terminal, relative to a gene structure, and involves
multiple exons from both genes, these six loci are not included in our
main dataset of human–primate terminal-exon distinctions. Absence
of human cDNA or EST support for the ﬁve novel intergenic splicing
events from nonhuman primates, despite the much greater depth of
human vs nonhuman transcriptome coverages in public databases,
suggests that these events are completely absent in humans, although
the possibility that they are extremely rare in humans cannot be
formally excluded. The GT–AG canonical introns spliced intergenically
between the adjacent genes in each case argue strongly against a
cloning artifact or chimerism explanation for these transcripts.
Discussion
Functional implications of terminal-exon differences at orthologous
protein-coding loci between humans and primates
Mapping cDNA/EST-derived transcriptome sequences to genome
assemblies has generated a wealth of gene structure data. However,
structural differences among primates at known conserved protein-
Fig. 2. Intergenic splicing in nonhuman primates. (A) Cases of intergenic splicing supported by nonhuman primate cDNA data. (B) A representative instance of intergenic splicing in
nonhuman primate cDNA data without human cDNA or EST support. Note. The orangutan cDNA CR861367 contains exons from two genes (tracked by vertical dotted lines). This ﬁts
the deﬁnition of intergenic splicing (joining of exons from adjacent but separate genes).
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scale.
We addressed this problem by comparing human transcriptome/
human genome alignments with orthologous nonhuman primate
transcriptome/human genome alignments. We searched for gene
structure differences between humans and nonhuman primates,
because these differences may contribute to species-speciﬁc pheno-
types. In contrast, existing studies have emphasized genomic se-
quence, not transcript, comparisons. An advantage of our approach is
that we are able to infer interspecies gene structure differences from
nonhuman primate cDNAs, even if the genomes of those species have
not been sequenced.
A diverse range of structural differences exists at orthologous loci
between humans and nonhuman primates, including terminal-exon
differences detected by our algorithm. These distinctions—in addition
to interspersed repeats, positive selection, and segmental duplica-
tions—may account for some phenotypic differences between humans
and other primates. Our approach establishes a foundation for tho-
rough, quantitative assessments of conserved genomic sequences at
orthologous loci that are incorporated into species-speciﬁc exons. By
enumerating known genes affected by structural differences at their
termini, we enable construction and testing of hypotheses regarding
the impact of speciﬁc ortholog structure differences on phenotypic
uniqueness.
Genomewide trends of 5′, 3′, UTR, and CDS participation in
species-speciﬁc primate gene structures probably cannot be inferred
from our small dataset. We were also unable to make functional con-
clusions unique to speciﬁc narrow phylogenetic groupings of pri-
mates, simply because the number of human mRNAs in GenBankexceeds by sixfold the number of all nonhuman primate mRNAs
combined. However, despite the limited transcriptome data, we were
still able to show structural differences at genes that previously were
not known to be structurally variant within primates, and to put a
lower bound on the number of UTR and CDS bases affected by human/
primate differences.
Six nonhuman primate transcripts are inferred to originate from
intergenic splicing—a phenomenon rarely observed in mammals and
whose mechanism and function are not well understood. The
corresponding human loci, despite numerous cDNAs/ESTs, have zero
human cDNA/EST support for intergenic splicing. Hence, species-
speciﬁc intergenic splicing may exist in nonhuman primates at these
loci. When attempting to translate the ORFs of the intergenically
spliced nonhuman primate cDNAs, we did not detect a potential for
chimeric fusion-protein translation in the nonhuman primates.
Intergenic splicing events may be a benign consequence of inefﬁcient
splicing or may exert a regulatory impact by omitting speciﬁc splice
sites and truncating the ORF.
Our application of controlled vocabularies to elucidate functional
biases within the subset of human genes having primate-speciﬁc
terminal-structure differences was not particularly informative. Biases
toward immune, behavior, and reproductive genes, while expected,
were not shown. This may be due to the small size of the curated
dataset or the preponderance of other types of human–primate differ-
ences (e.g., promoter substitutions, coding-sequence substitutions, or
segmental duplications, but not terminal-exon structural differences)
among genes implicated in previously characterized functional
distinctions within primates. However, four enrichment analysis
tools utilizing two controlled vocabularies suggested that speciﬁc
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of terminal-exon differences. Additionally, a literature-based perusal
of the 55-gene super-high-conﬁdence catalog of species-speciﬁc
terminal-exon changes in nonhuman primates pinpointed several
immunity, brain-size, and cancer genes, as well as genes previously
known to be subject to positive selection and structural variation. We
recognize that a random sampling of 55 genes might produce a few
members of these categories but it is nevertheless remarkable that the
particular genes in our dataset are candidates for structural modiﬁca-
tion in primate evolution. Gene ontology and controlled vocabularies
should be combined with individual-gene functional analyses for the
most comprehensive possible assessment of primate-speciﬁc function
enrichment in our subset of genes.
Ortholog structure comparisons of human genes and their counterparts
in a single nonhuman primate, Macaca fascicularis
Themacaque transcriptome has been sequencedmore deeply than
that of any other nonhumanprimate, thereby affording an opportunity
to perform gene structure comparisons systematically between
human and a single nonhuman primate species. We have hence
determined the distribution of all UCSC-mappedM. fascicularis cDNAs
in our analysis (Supplementary File bMacaca_fascicularis_mRNA_
counts.pptQ). A set of 9819 M. fascicularis full-length cDNAs from
GenBank had unambiguous precomputed UCSC BLAT mappings to the
HG18 human genome assembly. Of these, 3002 did not overlap any of
the 22,466 high-conﬁdence FANTOM3 human TUs as deﬁned in our
paper, while the other 6817 did overlap human TUs. Of the 6817 M.
fascicularis cDNAs with human TU support, 290 had a b1-kb difference
at the 5Vend but N100-kb difference at the 3Vend between human and
nonhuman genomic localizations of gene boundaries, or vice versa,
and also had greaterhumangenomic spans for themacaque-to-human
cDNA-to-genome alignment than for the human-to-human alignment,
reducing the likelihood that themacaque transcriptswouldprove to be
artifactually terminally truncated rather than reﬂect bona ﬁde ini-
tiation or termination sites. One hundred forty-three and 42macaque–
human cDNA matches were included in our total and super-high-
conﬁdence sets, respectively, of orthologous loci with terminal-exon
structure differences.
A high percentage of M. fascicularis testicular cDNAs were
previously reported to display macaque-speciﬁc 5′UTR exons unsup-
ported by human cDNA data [51]. In that particular study, no other
species were analyzed; only 622 human–macaque cDNA pairs were
detected (1 order of magnitude less than the 6817 macaque cDNAs
matching human TUs in our study); no clariﬁcations were made
regarding the exact methodology for declaring an exon to be provis-
ionally macaque-speciﬁc, and neither 3′UTRs nor intergenic splicing
was considered. Nevertheless, in conjunction with our report, studies
such as those by Osada et al. [51] provide a valuable integrated frame-
work for cataloging the complete scope of species-speciﬁc terminal-
exon gene structure differences in primates.
Future directions in human–primate ortholog gene structure
comparisons
We focused on a limited set of genes with single-end structural
differences between humans and primates and considered only the
subset of orthologs with N100kb separation of human and primate
mappings for the discrepant ends. Extending annotation to the much
larger set of genes with b100kb separation between discrepant-end
mappings is likely to uncover numerous additional examples of
primate-speciﬁc incorporation of conserved genomic sequences into
UTRs and CDSs. It may also help detect functional category enrichment
or depletion signals in this class of genes.
One logical implication of our study is that gene structure differ-
ences between orthologs may exist in places other than terminalexons. During manual curation of terminal-exon differences, we oc-
casionally observed internal exons arising from apparent species-
speciﬁc exoniﬁcation of conserved intragenic sequence at primate
orthologs (an example is the AB171923–BC030199 macaque– human
orthologous pair), but did not attempt to catalog this class of events
systematically. Internal-exon structural differences might hold sig-
niﬁcant potential for phenotypic impact, as they are expected to affect
primarily CDS rather than UTRs.
Our study does not utilize ab initio gene predictions or purely
computational evidence of homology. All human–primate gene
structure differences that we cataloged are supported by experimental
evidence (full-length and EST sequencing of cDNA libraries). Never-
theless, additional experimental work may aid in validation and mul-
tispecies comparisons of the gene structure differences. RT-PCR and
RACE validation of the 55 super-high-conﬁdence ortholog distinctions
may be an appropriate way to test whether the corresponding
terminal exons are indeed never used in human transcripts, even in
the same tissues and at the same developmental time points at which
they are used in nonhuman primates. Similarly, for the six intergenic-
splicing events, gene-speciﬁc nested RT-PCR in appropriate human
tissues may elucidate whether equivalent splicing events are ever
invoked in human.
The fundamental role of RNA-binding proteins in posttranscrip-
tional gene regulation through 3′UTR binding has been well estab-
lished [43]. Signal transduction pathways modulate gene expression
not only through DNA-binding transcription factor activities but also
through posttranscriptional mechanisms effected by RNA-binding
proteins [44]. In addition, the paramount importance of endogenous
microRNAs (miRNAs) as gene expression regulators has been expoun-
ded in a number of recent studies [45] indicating that miRNAs bind,
with imperfect but detectable homology, to speciﬁc target sites in 3′
UTRs of protein-codingmRNAs. Therefore, species-speciﬁc UTR subse-
quences may result in species-speciﬁc miRNA-mediated regulation of
conserved genes. Intraspecies polymorphisms in 3′UTRs that create
phenotypically important mRNA-recognition sites are already known
[46]. However, species-speciﬁc differences in orthologous UTRs that
enable or preclude speciﬁc RNA-binding protein interactions with
mRNAs have not been elucidated.
We have cataloged 54,272 bp of 5′UTR and 3′UTR sequence that is
included in nonhuman primate transcripts but rarely or never used in
their orthologous human counterparts. Of that sequence 12,622 bp
belongs to primate UTRs with zero human cDNA and EST support,
representing a conservative lower bound on the amount of species-
speciﬁc UTR recruitment in nonhuman primates. These putative
primate-speciﬁc UTRs can be mined by motif-ﬁnding tools for known
RNA-binding protein recognition and microRNA hybridization sites.
RNA-binding protein cognate motifs [47] and microRNA-binding
motifs [48] have been characterized computationally, although
complexity exists because of the impact of RNA structure on RNA-
binding proteins [47] and nonoverlapping expression proﬁles of
some microRNAs relative to predicted targets [48]. Our results can
provide the foundation for a pilot project aiming to establish how
conserved RNA-binding proteins, and/or microRNAs, may regulate
orthologous genes in humans and primates in species-speciﬁc ways
because of species-speciﬁc cognate sites in structurally variant
UTRs.
A premise of our analysis is that, to be detected, a primate-speciﬁc
terminal exon or exon extension must be mappable to the human
genome assembly. Primate-speciﬁc terminal cDNA fragments not
mappable to the human assembly would not have a human–primate
mapping distance discrepancy metric attached to them. However, our
analysis of human genes supported by orthologous primate cDNAs can
be extended to capture primate-speciﬁc cDNA termini that do notmap
to the human assembly. Such sequences may contribute additional
UTR and CDS fragments to the genomewide set of interspecies gene-
structure differences.
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as enriched in our set of structurally different genes, such as cyto-
skeletal organization and calcium binding, in HIV pathogenesis may
make it worthwhile to understand more about these processes in
nonhuman primatesT natural defense against retroviruses. The in-
sights gained may aid in human drug development.
In the course of compiling human and primate cDNA datasets
and cDNA–genome alignments, we developed several resources that
should be broadly useful to the primate comparative genomics com-
munity. In particular, we validated mappings of all publicly available
nonhuman primate cDNAs to the human genome (Supplementary File
bdistinct nonhuman primate cDNAs.xlsQ) and constructed tables that
link nonhuman and human GenBank accession numbers, gene names
(Supplementary File bgene_names_of_55_superhigh_conﬁdence_TUs.
xlsQ), genome coordinates (Supplementary File bcategorisation_of_
unique_terminal_exons(b).xlsQ), and species descriptors (Supplemen-
tary File bdistinct_nonhuman_primate_cDNAs.xlsQ). These tables can
facilitate any analysis of human genes that requires retrieval of
experimentally determined homologous transcript sequences from
nonhuman primates.
In an era of growing methodological sophistication in primate
comparative genomics, we were able to pinpoint intriguing gene
structure distinctions between humans and nonhuman primates,
including at several loci of known importance in primate evolution, by
applying a pipeline that focuses on terminal-exon differences. We
conclude that known protein-coding genes may harbor an under-
appreciated contribution to humanuniqueness through terminal-exon
distinctions that set humans apart from nonhuman primates.
Materials and methods
Identiﬁcation of nonhuman primate full-length cDNAs alignable with the
human genome
We used the following datasets (UCSC; http://genome.ucsc.edu) to
associate a nonhuman organism with a speciﬁc cDNA alignable with
the human genome:
• xenoMrna.txt.gz (HG18 version)
• gbCdnaInfo.txt.gz
• organism.txt.gz
In brief, we related the GenBank accession numbers of xenoMrna
sequences (nonhuman mRNA sequences aligned with the humanFig. 3. Relating GenBank accession numbers of nonhuman cDNAs aligned with the human
(organism). Red, blue, common ﬁelds used to join data together; bold, ﬁelds we are interesgenome) to the Linnaean binomen of their source organisms, through
the organism name ﬁeld of the CdnaInfo ﬁle (Fig. 3). Then we extrac-
ted all records whose organism name/ID referred to a nonhuman pri-
mate. We obtained the list of known primates from the NCBI Taxo-
nomy Browser.
Identiﬁcation and mapping of high-conﬁdence human TUs
We deﬁne high-conﬁdence human TUs as those supported by at
least one unambiguously mapped human cDNA and more than one
unambiguously mapped human EST in the FANTOM3 dataset. We
used the following FANTOM3 ﬁles:
• composite_mapping.txt.gz [32] (http://www.genereg.net/complex_
loci/dataset/hg17_v05/)
• TU.txt.gz [32] (http://www.genereg.net/complex_loci/dataset/
hg17_v05/)
• all_mrna.txt (http://genome.ucsc.edu)
We used the ﬁrst two ﬁles to identify high-conﬁdence human TUs, but
their initial mappings were to the older HG17 human assembly.
However, we decided to use the most recent (HG18) mappings of
nonhuman primate mRNAs on the human genome. Therefore, we
utilized all_mrna.txt to map FANTOM3Vs reference transcripts of the
human TUs to HG18 through their GenBank accession numbers.
Identiﬁcation of terminal-exon structure differences at orthologous
human–primate gene pairs from full-length cDNA-to-genome alignments
We undertook a structure-centric, rather than a sequence-centric,
approach to conservation. Speciﬁcally, we were interested in identify-
ing whether orthologous genes have species-speciﬁc unique exons.
Genomic conservation is not sufﬁcient to identify such exons; evi-
dence of transcription, from mRNA datasets, is required to identify a
genomically conserved region as transcribed.
Many types of structural differences are possible between ortho-
logous genes. These include terminal and internal exons speciﬁc to
one species, intron size differences, repeat insertions, short indels, and
differential splicing. Terminal-exon distinctions are easy to identify
because they involve alignment edges rather than internal blocks.
As artifactual truncation of cDNAs at 5Vand 3Vends during cDNA
library construction may occur, we focused only on genes that had
structural differences conﬁned to one end of the alignment (b1kb
difference at the 5Vend but N100kb difference at the 3Vend betweengenome (xenoMrna) and species names from which the nonhuman cDNAs originated
ted in.
Fig. 4. Examples of unique terminal exons in nonhumanprimate cDNAdata: genomic localization and annotation. (A) Example of a unique primate-speciﬁc terminal exon not found in any
humanmRNAs from theorthologous locus.Note.The terminal exon starting and endingpositions are at nucleotides (nt) 1268 and 1494, respectively (circled, top andmiddle panels). As the
terminal exon lies after the largest positive-strand ORF (opening reading frame) of 166–945 (boxed, lower panel), we conclude that its uniqueness affects slowly the 3′UTR. (B) Example of
implementing themajority-ruledeﬁnition to characterize a terminal exonasprimate-speciﬁc.We consideranynonhumanprimate terminal exonas unique if it is absent fromat least half of
the humanmRNAs. Here is a case of a unique primate-speciﬁc terminal exon (circled) that is present in theminority of humanmRNAs (dotted circle). Categorization is similar to that of (A).
(C) Example of a primate-speciﬁc terminal-exon extension. Note. From BL2SEQ of the macaque cDNA AB172644 and the orthologous human cDNA AB023202, we see that the stretch of
identity between themacaque and the human cDNAs starts at nt 364 of themacaque cDNA (circled, top panel). Hence, the unique portion of the terminal exon is fromnt 7 (circled, second
panel from top) to nt 363 on the primate cDNA, a region that encompasses the 5′UTR (nt 7–69) and part of the ORF (nt 70–363; the complete ORF is nt 70–504) as revealed by NCBI ORF
Finder. Thus, we concluded that the unique region, which is exonic in macaque but not in human in this locus, includes sequences from the 5′UTR and the CDS (but not the 3′UTR). The
unique N-terminal fragment of the CDS translates to 98 unique amino acids. UCSC Genome Browser, NCBI BL2SEQ, and NCBI ORF Finder were used to construct the illustration.
Fig. 5. Schematic illustration of UTR and CDS content determination for a primate-
speciﬁc terminal exon. Lines show the relationship between the terminal exon and the
UTR/CDS structure of the mRNA. The left line shows that base 1 of the terminal exon
(ﬁrst exon) is base 1 of the 5′UTR. The right line shows that the last base of the ﬁrst exon
is inside the CDS. Therefore, the terminal exon contains all of the 5′UTR and some of the
CDS in this example.
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vice versa). Human UTRs are generally b1kb [49]. Therefore, differ-
ences between human genome coordinates of human and ortholo-
gous nonhuman cDNA ends that are less than 1kb are assumed by us
to refer to the same gene because their mapping discrepancy is less
than the recognized size of untranslated regions. Unlike in ortholo-
gous transcript pairs with minimal differences at both ends, the genes
identiﬁed by us are unlikely to match trivially the orthologous gene
with perfect structural identity.
Identiﬁcation of speciﬁc human–primate gene structure differences at
orthologous loci
From human TU–primate xenoMrna orthologous pairs with
overlapping boundaries, we eliminated all pairs that had boundary
overlaps without exon overlaps. We then manually inspected all
candidates for structural differences and categorized the unique
nonhuman-primate-speciﬁc terminal exons as contributing 5′UTR,
CDS, 3′UTR, or a combination of the three to the primate mRNAs
they were a part of.
We favored manual inspection with the UCSC Browser due to the
small number of loci of interest and due to the inability of com-
putational pipelines to account correctly for all species differences
observed. An unanticipated advantage of manual annotation is that
we were able to identify several internal primate-speciﬁc exons and
mRNAs that were intergenically spliced. We applied a stringent
deﬁnition of primate-speciﬁc intergenic splicing. There had to be no
human or nonprimate cDNA or EST support for each putative inter-
genic splice variant; the splice variant had to bridge two adjacent,
known, nonoverlapping, annotated genes not connected by anyhuman cDNAs or ESTs; and at least one existing splice site in each of
the two genes, known from human cDNA/EST splicing analysis, had
to be utilized by the primate intergenic splice variant. The intergenic
splice sites were required to be GT–AG. Given these ﬁltering criteria,
the intergenic splices we uncovered most likely represent real
transcriptional events. Bidirectional RACE/RT-PCR and resequencing
in nonhuman primates would help conﬁrm the reality and tissue
speciﬁcity of these intergenic splicing events.
We had originally included human mRNAs whose accession
numbers start with bCRQ. However, UCSC currently recognizes these
accessions as unreliable. Therefore, we manually substituted human
bCRQ cDNA accessions with structurally most comparable bnon-CRQ
alternatives where available.
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it is absent from at least 50k of the human mRNAs (Fig. 4B). We
observed several kinds of interspecies structural differences at gene
ends.
Completely unique terminal exons
For this category of structural differences (Fig. 4A), we compared
two sets of parameters: (1) the starting and ending positions of the
terminal exon (obtained from UCSC Browser) and (2) the star-
ting and ending position of the ORF (obtained from NCBI ORF
Finder).
If the starting position of the terminal exon lay outside the range of
the ORF and before the ORF starting position, but the ending position
of the terminal exon lay within the ORF range, we concluded that the
5′UTR and part of the CDS belonging to the nonhuman mRNA were
unique (Fig. 5).
If the start of the species-speciﬁc unique portion of the terminal
exon in a nonhuman primate was inside the ORF, but the endwas after
the stop codon of the ORF, thenwe concluded that part of the CDS and
3′UTR belonging to the nonhuman mRNA were unique. If the unique
species-speciﬁc terminal exon was entirely within the ORF, we con-
cluded that only a part of the CDS of the nonhuman mRNA, and not
any UTR sequence of that mRNA, was unique. If the unique species-
speciﬁc terminal exon was entirely outside of the ORF and was either
before the start or after the end of the ORF, we concluded that either
the 5′UTR or the 3′UTR of the nonhuman mRNA, respectively, was
unique.
Partially unique terminal exons
In this category, a nonhuman primate cDNA, when mapped to the
human genome, shows that the primate ortholog of the human gene
has a longer terminal exon relative to the human gene's structure.
Therefore, only a contiguous portion of the terminal exon transcribed
in the primate, and not the entire primate terminal exon, aligns to
genomic sequence transcribed in human. We used NCBI BL2SEQ
[50] in every case to determine the exact coordinates of the portion
of the nonhuman primate cDNA that did not align with the
orthologously encoded human cDNA (Fig. 4C).
Understanding the effect of structural differences on biological pathways,
functions, and processes
To ﬁnd out whether gene structure differences between humans
and other primates affect speciﬁc biological pathways, functions, and
processes, we uploaded the human accession numbers from the 183-
gene total list and the 55-gene super-high-conﬁdence list to www.
pantherdb.org and three GO-based tools: David, FuncAssociate (beta
version), and Genecodis. We compared the accession numbers of the
human genes against both the bHuman AB 1700 genes (REF)Q and the
bNCBI: H. sapiens genes (REF)Q PantherDB lists.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ygeno.2008.05.006.
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